spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Mallinckrodt 

 HSMN NewsFeed - 2 Dec 2024
Mallinckrodt Completes Divestiture of Therakos(R) Business
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 5 Aug 2024
Mallinckrodt Reaches Agreement to Sell Therakos(R) Business to CVC for $925 Million
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 2 Apr 2024
NeoImmuneTech Appoints Dr. Luke Oh, Ph.D. as New Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Mar 2024
Mallinckrodt Announces Appointment of Paul O'Neill as Executive Vice President, Quality & Operations, Specialty Brands
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Mar 2024
Mallinckrodt Announces U.S. FDA Approval of Supplemental New Drug Application for Acthar(R) Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect(TM) Injector
Devices Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 15 Jan 2024
NeoImmuneTech Welcomes a New President for its Development and Business
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Nov 2023
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Aug 2023
Mallinckrodt Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate Capsules and Launches Product Used to Treat Attention-Deficit/Hyperactivity Disorder (ADHD)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 16 May 2023
Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry
Biopharmaceuticals
 HSMN NewsFeed - 12 Jan 2023
Mallinckrodt Announces Appointment of Dr. Peter Richardson, MRCP, as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Sep 2022
Mallinckrodt Announces Appointment of Lisa French as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Nov 2021
Board Member Michael Martino to Become Interim Chairman and CEO of Ampio Pharmaceuticals, Mike Macaluso to Take Medical Leave
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Feb 2021
Mallinckrodt Provides Regulatory Update on StrataGraft(R)
Devices Dermatology FDA
 HSMN NewsFeed - 4 Jan 2021
Endo Launches Authorized Generic Version of Amitiza(R) (lubiprostone) Capsules in the United States
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 16 Nov 2020
Mallinckrodt Announces Data from a Multicenter Post Hoc Analysis of Terlipressin in Patients with Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) at The Liver Meeting Digital Experience
Biopharmaceuticals
 HSMN NewsFeed - 10 Aug 2020
Mallinckrodt Announces U.S. FDA Filing Acceptance of Biologics License Application for StrataGraft(R) Regenerative Skin Tissue for Treatment of Adults with Deep Partial-thickness Thermal Burns
Biopharmaceuticals Regenerative Medicine FDA
 HSMN NewsFeed - 6 Apr 2020
Mallinckrodt Initiates Rolling Submission of Biologics License Application for StrataGraft(R) Regenerative Skin Tissue to U.S. Food and Drug Administration
Regenerative Medicine FDA
 HSMN NewsFeed - 12 Mar 2020
Mallinckrodt Evaluates the Potential Role for Inhaled Nitric Oxide to Treat COVID-19 Associated Lung Complications, Engages with Scientific, Governmental and Regulatory Agencies
Biopharmaceuticals
 HSMN NewsFeed - 25 Feb 2020
Mallinckrodt Announces Agreement in Principle for Global Opioid Settlement and Associated Debt Refinancing Activities
Biopharmaceuticals Litigation
 HSMN NewsFeed - 7 Jan 2020
HeartBeam Appoints Rich Ferrari and Marga Ortigas-Wedekind to its Board of Directors
Devices Cardiology Diagnostics Personnel
 HSMN NewsFeed - 23 Sep 2019
Mallinckrodt Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of StrataGraft(R) Regenerative Tissue in Patients with Deep Partial-thickness Thermal Burns
Regenerative Medicine
 HSMN NewsFeed - 15 Aug 2019
Mallinckrodt Announces Positive Top-Line Results from its Pivotal Phase 3 CONFIRM Trial of Terlipressin in Patients with Hepatorenal Syndrome Type 1 (HRS-1)
Biopharmaceuticals
 HSMN NewsFeed - 18 Jul 2019
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part Of A Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases
Biopharmaceuticals
 HSMN NewsFeed - 18 Jul 2019
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Jun 2019
Eiger Appoints Industry Veteran and Regulatory Affairs Expert Mark Mannebach, PhD, RPh as Vice President of Global Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 May 2019
Mallinckrodt Updates Plans for Company Separation and Spin-Off of Specialty Generics Business to Shareholders
Biopharmaceuticals Generics
 HSMN NewsFeed - 21 May 2019
Mallinckrodt Files Suit against U.S. Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) to Protect Medicaid Patient Access to Acthar(R) Gel
Biopharmaceuticals Reimbursement Litigation
 HSMN NewsFeed - 6 May 2019
Mallinckrodt Announces Encouraging Interim Analysis Results in Phase 4 Registry of INOmax(R) (Nitric Oxide) Gas for Inhalation for Pulmonary Hypertension in Neonates
Biopharmaceuticals
 HSMN NewsFeed - 15 Apr 2019
Data on Impact of Revised Consensus Recommendations on Time to Treatment and Serum Creatinine (SCr) at Treatment Start for Patients with Hepatorenal Syndrome Type 1 (HRS-1) Presented at the 2019 International Liver Congress(TM) (EASL)
Biopharmaceuticals
 HSMN NewsFeed - 12 Apr 2019
Mallinckrodt Completes Full Enrollment of its Phase 3 Clinical Trial for StrataGraft(R) Regenerative Skin Tissue
Devices Regenerative Medicine Wound Care
 HSMN NewsFeed - 18 Mar 2019
Bryan Reasons Joins Mallinckrodt as the Company's Chief Financial Officer (CFO)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Dec 2018
Mallinckrodt And NPXe Announce First Patient Enrolled In Phase 3 Trial Of Inhaled Xenon Gas Therapy
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 12 Dec 2018
Magnetic Insight Raises $18M to Support Commercial Growth of Magnetic Particle Imaging in Cell Therapy, Vascular and Oncology Applications
Devices Radiology Venture Capital Personnel
 HSMN NewsFeed - 27 Nov 2018
Hill-Rom Announces Executive Appointments
Devices Personnel
 HSMN NewsFeed - 26 Nov 2018
ORIC Pharmaceuticals Appoints Matt Panuwat as Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Oct 2018
U.S. FDA Announces Joint Advisory Committee Review of Mallinckrodt's Abuse-Deterrent, Immediate-Release Reformulation of Roxicodone(R) (Oxycodone Hydrochloride)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 23 Aug 2018
Mallinckrodt And NPXe Announce FDA Fast Track Designation For Phase 3 Trial Of Inhaled Xenon Gas Therapy
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Jun 2018
Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
Biopharmaceuticals
 HSMN NewsFeed - 24 Apr 2018
Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Apr 2018
OrphoMed Appoints Gary M. Phillips, M.D. as President and Chief Executive Officer
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 4 Apr 2018
Angus Russell to Succeed Melvin Booth as Mallinckrodt Chairman of the Board in May 2018
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Apr 2018
Mallinckrodt Names Paul R. Carter, Anne C. Whitaker to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2018
Oncternal Therapeutics Further Strengthens Leadership with Additions to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Mar 2018
Mallinckrodt Completes Sale Of RECOTHROM(R) And PREVELEAK(R) To Baxter
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 23 Feb 2018
Mallinckrodt Receives FDA Acceptance of Stannsoporfin New Drug Application Filing
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Feb 2018
Mallinckrodt Enrolls First Patient in Phase 1 Study of ExpressGraft(TM)C9T1 Skin Tissue
Devices Wound Care
 HSMN NewsFeed - 13 Feb 2018
Mallinckrodt Completes Acquisition Of Sucampo Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Feb 2018
Mark Casey Joins Mallinckrodt as General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2018
Eiger BioPharmaceuticals Announces Appointment of Commercial Operations Industry Veteran Eldon Mayer to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2018
Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 26 Dec 2017
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Dec 2017
Mallinckrodt Completes Acquisition of Ocera Therapeutics and OCR-002, Its Proprietary Therapy in Development for Treatment of Hepatic Encephalopathy
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Nov 2017
Outpost Medicine Appoints Scott Byrd as Chief Executive Officer and Raises $20 Million in Series A Financing Extension
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 2 Oct 2017
Mallinckrodt Licenses Inhaled Xenon Gas Therapy Development Product
Biopharmaceuticals Licensing
 HSMN NewsFeed - 18 Jul 2017
U.S. FDA Designates Mallinckrodt's StrataGraft(R) as Regenerative Medicine Advanced Therapy
Regenerative Medicine FDA
 HSMN NewsFeed - 10 Jul 2017
Novus Therapeutics Announces Change in Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jul 2017
Industry Veteran Mr. Steve Gannon Joins enGene's Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jun 2017
Charles J. Casamento Appointed Chairman of Relmada Therapeutics Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Apr 2017
Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago(R) (safinamide) in Canada
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 14 Nov 2016
First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar(R) Gel for Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 28 Oct 2016
Mallinckrodt Builds UK Presence With New Global Corporate Headquarters in Staines-upon-Thames
Biopharmaceuticals
 HSMN NewsFeed - 23 Sep 2016
Validity of Mallinckrodt's INOMAX(R) Patent Claims Upheld
Biopharmaceuticals Devices Litigation
 HSMN NewsFeed - 1 Sep 2016
Mallinckrodt Completes Acquisition Of Stratatech Corporation, A Regenerative Medicine Company Focused On Proprietary Therapeutic Human Skin Substitute Products
Devices Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 25 Aug 2016
Mallinckrodt Receives FDA Fast-Track Designation for Synacthen(R) Depot IND Application
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Aug 2016
Mallinckrodt To Acquire Stratatech Corporation, A Regenerative Medicine Company Focused On Proprietary Therapeutic Human Skin Substitute Products
Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 9 Jun 2016
NuView Life Sciences Appoints Joel R. Timberlake as President of US Radiopharmaceuticals
Biopharmaceuticals Radiology Oncology Personnel
 HSMN NewsFeed - 2 May 2016
Endo Announces U.S. District Court Ruling Upholding OPANA(R) ER Intellectual Property
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 29 Feb 2016
Asterias Biotherapeutics Appoints Stephen L. Cartt President and Chief Executive Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 26 Feb 2016
Catalyst Pharmaceuticals Appoints Brian Elsbernd as Senior Vice President of Legal and Compliance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2016
Guerbet receives FDA 510k clearance for the OptiOne(TM) Single-Head Contrast Delivery System
Devices Radiology FDA
 HSMN NewsFeed - 1 Feb 2016
Mallinckrodt Completes Acquisition Of Three Commercial-Stage, Global Specialty Hemostasis Brands From The Medicines Company
Devices Surgery Acquisitions
 HSMN NewsFeed - 18 Jan 2016
Michael Martino Named President and Chief Executive Officer of HemaFlo Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Oct 2015
Mallinckrodt's INOmax(R) Approved In Australia And Japan For Pulmonary Hypertension In Conjunction With Heart Surgery
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Jul 2015
POZEN Appoints Scott Charles Senior Vice President of Finance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Nov 2014
Nuvo Research(R) reacquires Pennsaid(R) 2% rights to South America, Central America, South Africa and Israel
Biopharmaceuticals Distribution
 HSMN NewsFeed - 22 Jul 2014
Multi-Center Trial Shows Significant Pain Relief for Spine Cancer Patients Following Targeted Radiofrequency Ablation Treatment
Devices Oncology
 HSMN NewsFeed - 30 Jun 2014
Cidara Therapeutics Completes $32 Million Series A Financing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 May 2014
Mallinckrodt Pharmaceuticals’ New Drug Application Accepted for Review by FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Apr 2014
Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Enter Into Definitive Merger Agreement Under Which Mallinckrodt Will Acquire Questcor For Approximately $5.6 Billion, Creating A Diversified, High-Growth Specialty Pharmaceuticals Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Mar 2014
Mallinckrodt plc Completes $1.4 Billion Acquisition of Cadence Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Mar 2014
Caliber Imaging & Diagnostics Names Robert T. Kelley to Vice President of U.S. Sales
Devices Radiology Personnel
 HSMN NewsFeed - 11 Feb 2014
Mallinckrodt plc to Acquire Cadence Pharmaceuticals, Inc. for $14.00 Per Share, in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Jan 2014
Mallinckrodt Pharmaceuticals and Medtronic Announce Clinical and Commercial Collaboration
Biopharmaceuticals Devices Drug Delivery Neurology
 HSMN NewsFeed - 9 Jan 2014
Mallinckrodt Pharmaceuticals and Zogenix to End Co-Promotion Agreement
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 25 Nov 2013
U.S. Food and Drug Administration (FDA) Extends Review of Mallinckrodt’s New Drug Application for XARTEMIS(TM) XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets (CII)
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Oct 2013
Mallinckrodt Pharmaceuticals Announces Executive Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Aug 2013
Mallinckrodt Pharmaceuticals Signs Distribution Agreement with Amneal Pharmaceuticals LLC
Biopharmaceuticals Generics Distribution
 HSMN NewsFeed - 1 Jul 2013
Covidien Completes Separation of Pharmaceuticals Business
Biopharmaceuticals Devices Mergers & Acquisitions
 HSMN NewsFeed - 24 May 2013
Covidien Board of Directors Approves Separation of Pharmaceuticals Business and Declares Dividend of Mallinckrodt Ordinary Shares
Biopharmaceuticals
 HSMN NewsFeed - 23 Apr 2013
Nuvo Research announces European launch of Pliaglis(R) by Galderma
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 21 Jan 2013
Mallinckrodt Announces Approval of New Gablofen(R) Prefilled Syringe
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 22 Oct 2012
Nuvo and Galderma Announce FDA Approval of Pliaglis(R)
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 2 Oct 2012
Mallinckrodt Completes Acquisition of CNS Therapeutics, Inc.
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 27 Aug 2012
FDA Approves Mallinckrodt’s EXALGO(R) (hydromorphone HCl) Extended-Release Tablets 32 mg (CII) for Opioid-Tolerant Patients with Moderate-to-Severe Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Aug 2012
Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 May 2012
Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
Devices Personnel
 HSMN NewsFeed - 21 Feb 2012
Pliaglis(R) Regulatory Update
Biopharmaceuticals
 HSMN NewsFeed - 16 Nov 2011
Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2011
Aircraft Medical Signs Multinational Distribution Agreement with Covidien for McGRATH® MAC Video Laryngoscope
Devices Distribution
 HSMN NewsFeed - 3 May 2011
Delcath Names Harold C. Mapes as Executive Vice President of Global Operations
Devices Drug Delivery Oncology Personnel
 HSMN NewsFeed - 10 Mar 2011
Covidien Receives FDA Approval for South African-Produced Medical Isotope Based on Low-Enriched Uranium
Devices Radiology FDA
 HSMN NewsFeed - 10 Feb 2011
Covidien Receives FDA Approval for Fentanyl Transdermal System Patch
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 10 Jan 2011
CASMED Announces Key Addition to Executive Management Team
Devices Monitoring Personnel
 HSMN NewsFeed - 8 Nov 2010
ZIOPHARM Oncology Appoints Brian L. Hamilton, M.D., Ph.D., as Senior Vice President, Clinical Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Oct 2010
Covidien Demonstrates Breakthroughs in Minimally Invasive Surgery and Soft Tissue Repair at 2010 American College of Surgeons Clinical Congress (ACS)
Devices Surgery
 HSMN NewsFeed - 14 Sep 2010
AngioDynamics Strengthens Executive Team with Key Appointments
Devices Personnel
 HSMN NewsFeed - 10 Aug 2010
Avid Radiopharmaceuticals Expands R&D Capabilities with Appointment of Dr. Mark A. Mintun as Chief Medical Officer
Biopharmaceuticals Radiology Neurology Personnel
 HSMN NewsFeed - 29 Jun 2010
Siemens Launches SIERRA Dose Reduction Initiative in Computed Tomography
Devices Radiology
 HSMN NewsFeed - 1 Jun 2010
Tetraphase Closes $45 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Apr 2010
Roxane Laboratories, Inc. Announces the Launch of Imipramine Pamoate Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 Mar 2010
MAKO Surgical Corp. Announces Additions to Senior Management Team
Devices Surgery Orthopaedic Personnel
 HSMN NewsFeed - 2 Mar 2010
FDA Approves EXALGO (Hydromorphone HCL) Extended-Release Tablets
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Dec 2009
Stockholders of CombinatoRx and Neuromed Vote for Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Dec 2009
Covidien Announces Definitive Agreement to Sell U.S. Radiopharmacies
Biopharmaceuticals
 HSMN NewsFeed - 20 Nov 2009
FDA Extends Review of NDA for Exalgo
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Nov 2009
Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
Biopharmaceuticals
 HSMN NewsFeed - 19 Oct 2009
Covidien Announces Global Launch of Mallinckrodt TaperGuard Line of Endotracheal Tubes
Devices
 HSMN NewsFeed - 30 Sep 2009
Covidien Receives FDA Clearance for its Mallinckrodt TaperGuard Evac Endotracheal Tube
Devices FDA
 HSMN NewsFeed - 2 Jul 2009
CombinatoRx and Neuromed Sign Merger Agreement
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 17 Jun 2009
Mylan Receives FDA Approval for Additional Strength of Generic Restoril(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 Jun 2009
Neuromed Announces Sale of U.S. Rights to Drug Candidate Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) to Mallinckrodt
Biopharmaceuticals
 HSMN NewsFeed - 2 Feb 2009
Molecular Insight Pharmaceuticals Announces Board and Senior Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jan 2009
CardioNet Appoints Matthew Margolies Senior Vice President of Sales
Devices Cardiology Monitoring Personnel
 HSMN NewsFeed - 7 Jan 2009
Siteman Cancer Center Adds Second TomoTherapy(R) Hi-Art(R) Treatment System
Devices Oncology
 HSMN NewsFeed - 23 Sep 2008
Covidien Announces FDA Approval for its Generic Myocardial Perfusion Imaging Kit
Biopharmaceuticals Generics Radiology FDA
 HSMN NewsFeed - 2 Sep 2008
Purdue Pharma L.P. Announces Resolution of OxyContin(R) Patent Lawsuit with Mallinckrodt Inc.
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 2 Sep 2008
Covidien Announces Agreement with Purdue Pharma L.P. Enabling Launch of Oxycodone Hydrochloride Extended-Release Tablets
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 19 May 2008
Zimmer Holdings Names Mark C. Throdahl Group President, Global Businesses
Devices Orthopaedic Personnel
 HSMN NewsFeed - 27 Feb 2008
Covidien Announces Tentative FDA Approval for Its Generic Myocardial Perfusion Imaging Kit
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 7 Feb 2008
MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jan 2008
Palatin Technologies Announces Litigation Settlement With Competitive Technologies
Biopharmaceuticals Licensing Litigation
 HSMN NewsFeed - 3 Dec 2007
VNUS Medical Technologies Appoints Kirti Kamdar as Senior Vice President of Research & Development
Devices Personnel
 HSMN NewsFeed - 26 Sep 2007
Palatin Technologies Announces Reduction of Workforce
Biopharmaceuticals
 HSMN NewsFeed - 30 Aug 2007
King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
Biopharmaceuticals
 HSMN NewsFeed - 16 Aug 2007
Covidien's MRidium Infusion Pump Delivers Industry-Leading Functionality for Magnetic Resonance Imaging
Devices
 HSMN NewsFeed - 5 Jul 2007
Auriga Laboratories Appoints Rick Coulon Vice President of Consumer Brands
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Apr 2007
Tyco International to Acquire AbsorbaTack(TM) Technology From Sorbx LLC
Devices Mergers & Acquisitions
 HSMN NewsFeed - 9 Apr 2007
Alpharma Announces New Sales and Marketing Leadership in its Pharmaceuticals Business
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Mar 2007
Timothy R. Wright Appointed President of Tyco Healthcare's Pharmaceutical Products and Imaging Solutions Units
Biopharmaceuticals Devices Personnel
 HSMN NewsFeed - 13 Mar 2007
Mallinckrodt Initiates Voluntary Imaging Product Recall
Devices Radiology Product Recall
 HSMN NewsFeed - 13 Mar 2007
ADVENTRX Appoints Vice President of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Feb 2007
IRadimed Corporation Awarded Novation Contract for its award winning MRidium(TM) MRI IV Pump System and Remote Control
Devices Group Purchasing
 HSMN NewsFeed - 25 Jan 2007
Tyco Healthcare Announces New Name
Devices Biopharmaceuticals
 HSMN NewsFeed - 5 Jan 2007
Tyco Announces Nominees to Board of Directors for Tyco Healthcare
Devices Personnel
 HSMN NewsFeed - 3 Jan 2007
Mallinckrodt Signs New Imaging and Radiopharmaceutical Agreements With Premier Purchasing Partners
Devices Biopharmaceuticals Radiology Group Purchasing
 HSMN NewsFeed - 3 Jan 2007
Hospitals, Healthcare Providers to Save with Premier Contrast Media, Injectors, Radiopharmaceutical Products and Distribution Agreements
Devices Biopharmaceuticals Radiology Group Purchasing
 HSMN NewsFeed - 20 Dec 2006
Palatin Technologies and King Pharmaceuticals Complete Enrollment in Pre-Menopausal Cohort of a Phase 2 Clinical Trial Evaluating Bremelanotide in Pre- and Post-Menopausal Female Sexual Dysfunction Patients
Biopharmaceuticals
 HSMN NewsFeed - 11 Dec 2006
Tyco Unveils Senior Management Team to Lead Tyco Healthcare as Independently Traded Company
Devices Personnel
 HSMN NewsFeed - 28 Nov 2006
Valleylab Announces New, Integrated ForceTriad(TM) Energy Platform for Electrosurgery
Devices Surgery
 HSMN NewsFeed - 6 Nov 2006
Palatin Technologies and King Pharmaceuticals Report Results For Two Phase 2B Clinical Trials Evaluating Bremelanotide in Male Erectile Dysfunction Patients
Biopharmaceuticals
 HSMN NewsFeed - 28 Sep 2006
OmniSonics Appoints Dr. Elvira Lang as Vice President and Chief Medical Officer
Devices Interventional Personnel
 HSMN NewsFeed - 27 Sep 2006
Dr. Robert C. Moellering, Jr. Joins NanoBio Corporation's Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jul 2006
CryoCath Announces Management Change
Devices Cardiology Personnel
 HSMN NewsFeed - 18 Jul 2006
Tyco International Signs Agreement to Acquire Confluent Surgical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 31 May 2006
ZOLL Medical Corporation Announces Appointment of New Director
Devices Personnel
 HSMN NewsFeed - 22 May 2006
E-Z-EM Launches New CO(2) Insufflator for Gastrointestinal Endoscopic Procedures
Devices
 HSMN NewsFeed - 11 May 2006
Tyco Healthcare / Mallinckrodt and IRadimed Announce North American Agreement
Devices
 HSMN NewsFeed - 8 May 2006
FDA Clears Valleylab's Cool-tip(TM) RF Ablation System for Use in Ablating Non-Resectable Liver Tumors
Devices Surgery Oncology FDA
Return to NewsFeed  

 Additional items found! 109

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 109 additional stories matching:
Mallinckrodt
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.